Top cardiologists with the University of Miami are available to provide expert perspective on cardiac arrest among athletes #DamarHamlin
University of Miami Health System, Miller School of Medicine
A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.
The Smidt Heart Institute at Cedars-Sinai was named a Mitral Valve Repair Reference Center, a recognition awarded to select U.S. medical centers that have a record of superior clinical outcomes resulting from evidence-based, guideline-directed degenerative mitral valve repair.
Health article about how the holidays can add stress to your life, and left unchecked, the stress and anxiety can be detrimental to physical and mental health, including heart health.
Se você é fumante, você pode estar no ponto em que quer parar de fumar, mas precisa de um guia para mostrar a você como ir de uma vida de tabagismo, “aqui”, para uma vida sem tabagismo, “lá”. Aqui você encontra dicas para começar a sua jornada livre do tabagismo do Dr. Patrick Bigaouette, psiquiatra do Sistema de Saúde da Mayo Clinic, em Mankato, Minnesota, EUA.
Si usted fuma, es posible que esté en un punto en el que quiere dejar de hacerlo, pero necesita una guía sobre cómo llegar del "aquí" de fumar al "allí" de no fumar. Aquí hay sugerencias sobre cómo comenzar el camino libre de tabaco del Dr. Patrick Bigaouette, psiquiatra del Sistema de Salud de Mayo Clinic en Mankato, Minnesota.
إذا كنت مدخنًا ، فربما تكون قد وصلت إلى النقطة التي تريد التوقف عندها ، لكنك بحاجة إلى دليل ينقلك من "هنا" ، أي أنني أدخن إلى "هناك" ، أي تركت. فيما يلي نصائح حول كيفية البدء في رحلتك للإقلاع عن التدخين من MD ، MD ، Patrick Pejauette ، MD ، من Mayo Clinic Health System في مانكاتو ، مينيسوتا..
如果您是一名抽烟者,您可能正处于想要戒烟的阶段,但需要一份指南,指引您如何从抽烟的“这里”到达不抽烟的“那里”。以下是明尼苏达州曼凯托妙佑区域医疗系统的精神病学家Patrick Bigaouette医学博士关于如何开始您的无烟之旅的建议。
Researchers identified a protein linked with the onset of anthracycline-associated cardiac toxicity. In two studies conducted in women undergoing treatment for breast cancer, levels of a protein known as hemopexin circulating in the blood were associated with increased cardiac toxicity.
The Smidt Heart Institute at Cedars-Sinai welcomes four new specialists to its Department of Cardiology: interventional cardiologist Aakriti Gupta, MD, electrophysiologists Eric Braunstein, MD, and Archana Ramireddy, MD, and adult congenital cardiologist Prashanth Venkatesh, MD.
In a new study evaluating the Mediterranean diet and adverse pregnancy outcomes, investigators from the Smidt Heart Institute at Cedars-Sinai found that women who conceived while adhering to the anti-inflammatory diet had a significantly lower risk of developing preeclampsia during pregnancy.
The evidence-based health benefits of walking continue to accumulate, according to ongoing research by a University of Massachusetts Amherst physical activity epidemiologist, who leads an international consortium known as the Steps for Health Collaborative.
The University of Chicago Medicine transplant team performed the health system's first donated-after-circulatory death (DCD) heart transplant on Nov. 19, 2022. The DCD technique is expected to help heart patients get transplants faster. Donor hearts are traditionally recovered from brain-dead donors, a process known as donation after brain death (DBD).
Using the CRISPR-Cas9 gene editing system, UT Southwestern researchers corrected mutations responsible for a common inherited heart condition called dilated cardiomyopathy (DCM) in human cells and a mouse model of the disease.
Drinking two or more cups of coffee a day was associated with twice the risk of death from cardiovascular disease among people with severe hypertension compared to non-coffee drinkers, in a study of more than 18,600 men and women in Japan.
Nothing beats a good soak in a hot bath, and when it really hits the spot, you can almost feel your worries and ailments diffusing out into steam.
Using machine learning and clinical data from electronic health records, researchers at the Icahn School of Medicine at Mount Sinai in New York constructed an in silico, or computer-derived, marker for coronary artery disease (CAD) to better measure clinically important characterizations of the disease.
Older heart failure patients who feel that they have lost their social role amongst friends and family are more likely to suffer poor clinical outcomes.
Researchers have devised a new biomarker-based strategy to screen for a rare and deadly myocarditis complication caused by immune checkpoint inhibitors that are used to treat several cancers. In the study, nearly all patients with cancer who were treated with ICIs had early signs of muscle destruction and liver damage.
Investigators from the Smidt Heart Institute at Cedars-Sinai have identified how biological pacemaker cells—cells that control your heartbeat—can “fight back” against therapies to biologically correct abnormal heartbeat rates.
Both hot and cold environments trigger a stress response in the human body and can lead to cardiovascular problems.
Researchers funded by the British Heart Foundation (BHF) at the University of Bristol have developed ‘stem cell plasters’ to revolutionise the way surgeons treat children living with congenital heart disease, so they don’t need as many open-heart operations.
Researchers at Memorial Sloan Kettering Cancer Center (MSKCC) in New York have discovered that common cancer treatments, such as radiotherapy or anthracycline drugs, cause long-term damage to heart tissue by activating a key inflammatory signaling pathway. The study, published December 19 in the Journal of Experimental Medicine (JEM), suggests that inhibiting this pathway could reduce the chances of cancer survivors suffering heart disease later in life.
The world-renown journal Nature, named Muhammad Mohiuddin, MD, DSc, Program and Scientific Director of the Cardiac Xenotransplantation Program at the University of Maryland School of Medicine (UMSOM), on its annual list of 10 people who helped shaped science in 2022.
New research at Cleveland Clinic expands the link between what we eat and how the gut microbiome impacts our susceptibility to develop different diseases – in this case, how a specific gut microbe-generated byproduct is linked to heart failure risk.
With modern therapies for heart failure (HF) with reduced ejection fraction (HFrEF), some patients can improve their cardiac function during treatment.
Yvette Honda-Schumacher was 20 weeks pregnant and had just had a routine anatomy ultrasound when she was surprised to hear that a cardiologist was asked to come into the exam room.
Cardiology researchers at Albert Einstein College of Medicine and Montefiore Health System have received a five-year, $5.2 million grant from the National Institutes of Health (NIH) to explore the underlying causes of heart failure among Hispanics/Latinos, who are at heightened risk for heart disease. Investigators will take a novel approach to assess risk: by simultaneously evaluating heart function and the relationship between the heart and the aorta, the large artery that conveys oxygen-rich blood from the heart’s left ventricle to the rest of the body.
Dr. Ryan Kaple joins structural heart colleagues Dr. Tilak Pasala and Dr. Lucy Safi to offer advanced clinical trials and surgical systems that enhance patient outcomes
UC San Francisco surgeons have performed the health system’s 20,000th solid organ transplant, making it just the third in the nation to reach that milestone. The surgery also marked UCSF Health’s first donation after circulatory death (DCD) heart transplant, a procedure performed by only about twenty health systems in the U.S.
Researchers have uncovered a protein produced by the immune system, suPAR, that causes atherosclerosis. Investigators say it's the first immune target to treat cardiovascular disease, which affects over 1 billion people worldwide. Researchers believe treatment could be developed within five years.
People with cluster headaches may be more than three times more likely to have other medical conditions such as heart disease, mental disorders and other neurologic diseases, according to a study published in the December 14, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Cedars-Sinai aortic aneurysm expert Ali Azizzadeh, MD is available for interviews about the telltale signs, risk factors and available treatment options for aortic aneurysms, a rare but often fatal condition.
What are the keys to “successful” or optimal aging? A new study followed more than 7000 middle aged and older Canadians for approximately three years to identify the factors linked to well-being as we age.
With numerical simulations, researchers have demonstrated a new way to time weak electrical pulses that can stop certain life-threatening arrhythmias. Publishing their work in Chaos, the group shows that timed pulses are successful in ending atrial and ventricular fibrillations. The study provides early evidence that one theorized approach to controlling fibrillations – adaptive deceleration pacing – can improve the performance of defibrillators.
Extremely hot and cold temperatures both increased the risk of death among people with cardiovascular diseases, such as ischemic heart disease (heart problems caused by narrowed heart arteries), stroke, heart failure and arrhythmia, according to new research published today in the American Heart Association’s flagship journal Circulation.
Investigators from the Smidt Heart Institute at Cedars-Sinai validated the link between a debilitating heart condition and COVID-19 and, to a lesser extent, a novel link between the same condition and COVID-19 vaccination.
There is a critical need for non-invasive solutions to monitor heart failure progression around the clock. This novel wearable device is based on sensors embedded in a lightweight belt that monitors thoracic impedance, electrocardiogram (ECG), heart rate and motion activity detection. The device was tested in different conditions including sitting, standing, lying down and walking. Findings showed that all of sensors kept track of the changes for all of the different conditions.
Exposure to extremely hot or cold temperatures increases a heart disease patient’s risk of dying, according to a new study published today in the American Heart Association’s journal Circulation.
Celebrating one of the largest gifts ever to Michigan Medicine of $50 million, the health system will name its new hospital for longtime philanthropists D. Dan and Betty Kahn. The $920 million facility will include 264 private inpatient rooms capable of converting into intensive care, a top-notch neurosciences center, and specialty services for cardiovascular and thoracic care. It will also feature 20 surgical and three interventional radiology suites.
The December 2022 issue features 10 articles on the latest research in toxicology.
New research suggests that former professional football players may face accelerated aging, despite past research showing they have life spans similar or longer than the general population In the new study, retired football players reported shorter health spans — defined as years free of disease – than men in the general population Two age-related diseases — arthritis and dementia — were found more commonly among former football players, compared with men of the same age in the general population Additionally, hypertension and diabetes were more common among younger former players, those ages 25 to 29, compared with same-age men from the general population. The results warrant further study to define the biochemical, cellular, and physiologic mechanisms behind premature aging in former football players
Investigators at Cedars-Sinai conduct more than 2,500 research projects annually, and many of these studies have resulted in new treatments or have opened the door to future innovations.
Nearly half of Americans with Medicare now get their health insurance coverage through a private company that takes part in the federal government’s Medicare Advantage program.
Teens with Type 1 diabetes (T1D) who took bromocriptine, a medication used to treat Parkinson’s disease and Type 2 diabetes, had lower blood pressure and less stiff arteries after one month of treatment compared to those who did not take the medicine, according to a small study published today in Hypertension, an American Heart Association journal.